Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Government Funding and Venture Capital Investments Across Developed Markets?
4.2.2 Increasing Applications of HCS in Life Science Research?
4.2.3 Advancements in Informatic Solutions and Imaging Systems?
4.3 Market Restraints
4.3.1 Lower Adoption of HCS Instruments Due to Their High Prices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Instruments
5.1.1.1 Cell Imaging and Analysis Systems
5.1.1.2 Flow Cytometers
5.1.2 Consumables
5.1.2.1 Reagents and Assay Kits
5.1.2.2 Microplates
5.1.2.3 Other Consumables
5.1.3 Software
5.1.4 Other Products
5.2 By Application
5.2.1 Primary and Secondary Screening
5.2.2 Target Identification and Validation
5.2.3 Toxicity Studies
5.2.4 Compound Profiling
5.2.5 Other Applications
5.3 By End User
5.3.1 Pharmaceutical and Biotechnology Companies
5.3.2 Academic and Government Institutions
5.3.3 Contract Research Organization
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GE Healthcare
6.1.2 Danaher Corporation
6.1.3 Perkinelmer Inc.
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 Becton, Dickinson and Company
6.1.6 Biotek Instruments Inc.
6.1.7 Bio-Rad Laboratories Inc.
6.1.8 Yokogawa Electric Corporation
6.1.9 Merck KGaA


7 MARKET OPPORTUNITIES AND FUTURE TRENDS